Due to regulatory requirements, access to our product catalog is restricted to verified researchers and institutional professionals.
$167.00
81 in stock
Product Usage:
These products are intended for research use only.
This designation permits the use of these research chemicals strictly for in vitro testing and laboratory experimentation. All product information provided on this website is for educational purposes only. Any form of bodily introduction into humans or animals is strictly prohibited by law. These products must be handled only by licensed and qualified professionals.
These products are not drugs, foods, or cosmetics and must not be misbranded, misused, or mislabeled as such.
Retatrutide, a GLP-1/GIP/GCGR receptor agonist, significantly lowers blood glucose levels, supports weight management (6.6%-22.1%), reduces major cardiovascular events, and improves overall metabolic health by enhancing insulin sensitivity and lipid metabolism (PMID: 38356208, PMID: 37366315, PMID: 37902090).
Retatrutide (GLP-3) 15mg is a synthetic triple receptor agonist peptide studied in preclinical and clinical research for its interactions with GLP-1, GIP, and glucagon receptor (GLP-1/GIP/GCGR) binding and downstream signaling pathway analysis. Available exclusively for licensed research and laboratory use.
Retatrutide has been investigated in peer-reviewed studies examining triple incretin receptor binding affinity, pancreatic signaling modulation, and associated metabolic pathway mechanisms. References are provided for informational purposes relating to published scientific literature.
For research use only. Not for human or animal consumption. Not a drug, food, or cosmetic. Must be handled by licensed, qualified professionals in a controlled laboratory setting.
For research purposes only. Not for human use.
| Weight | 0.03 kg |
|---|---|
| Title | Default Title |
All Articles And Product Information Provided On This Website Are For Informational And Educational Purposes Only.
The products offered on this website are furnished for in-vitro studies only. In-vitro studies {Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
LifeLinkResearch.com uses cookies to enhance your experience. By continuing to use our website, you consent to our use of cookies in accordance with our Cookie Policy.
You confirm having read our waiver and disclaimer of liability. By using this site, you agree to all terms herein.
Products on this site are intended only for research and development; they are not for human consumption and that I am a qualified individual 21 years and older. Statements and products on this site have not been evaluated by the U.S. Food and Drug Administration. Your continued use of this site implies understanding and acceptance of these conditions.
